|
Kenneth King is the President of Ken King Consulting. The firm assists small to mid size companies in the development of global regulatory strategies and their local implementation through formal relationships around the world. They also provide secure document management and provide electronic publishing using Common Technical Document templates. Dr. King has over 30 years of progressive technical and business management experience with pharmaceutical R&D with a primary focus on regulatory affairs. His strong technical background and experience form the basis of constructive working relationships with regulatory agencies as well as with internal constituencies. Prior to forming Ken King Consulting, Dr. King was Senior Vice President, Worldwide Development and Director, U.S. Regulatory Affairs at Pfizer Research and Development. He worked with the FDA, PhRMA, BIO and congressional staff on the reauthorization of PDUFA II. Prior to his role at Pfizer, he held positions at Parke-Davis as Senior Vice President, Worldwide Regulatory Affairs, and at Pharmacia & Upjohn, Inc. as Vice President, Global Regulatory Affairs. Earlier, Dr. King held positions at Pharmacia, Boots Pharmaceuticals, Watson Laboratories, and G.D. Searle and Company. He received his Ph.D. in Pharmaceutical Chemistry from the University of Illinois.
| 